E Fund Management’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$34.4K Buy
+13,373
New +$39.2K ﹤0.01% 450
2024
Q3
– Sell
-13,051
Closed -$60.9K – 362
2024
Q2
$60.9K Sell
13,051
-25,031
-66% -$141K ﹤0.01% 312
2024
Q1
$283K Buy
38,082
+18,948
+99% +$157K 0.02% 284
2023
Q4
$194K Sell
19,134
-6,321
-25% -$55.5K 0.01% 287
2023
Q3
$199K Sell
25,455
-5,468
-18% -$46.9K 0.02% 262
2023
Q2
$254K Sell
30,923
-7,932
-20% -$69.1K 0.02% 239
2023
Q1
$282K Sell
38,855
-1,525
-4% -$13.6K 0.02% 236
2022
Q4
$358K Buy
40,380
+10,288
+34% +$113K 0.03% 201
2022
Q3
$368K Sell
30,092
-9,249
-24% -$144K 0.03% 200
2022
Q2
$465K Buy
39,341
+21,529
+121% +$288K 0.04% 158
2022
Q1
$339K Buy
+17,812
New +$331K 0.01% 170

Other funds holding EDIT

E Fund Management's EDIT Position: Q3 2026 in Review

E Fund Management opened a new position in Editas Medicine (EDIT) in Q3 2026: 13,373 shares worth $34.4K. The stake represents ﹤0.01% of the portfolio and ranks #450 among its holdings. This is a return to the name: E Fund Management previously reported a position in EDIT as recently as Q2 2024.

E Fund Management first reported a position in EDIT in Q1 2022 and has held it in 11 quarters since. The position peaked at $465K in Q2 2022. 221 funds tracked by Wall St. Rank hold EDIT as of Q3 2026.

  • E Fund Management held 13,373 shares of Editas Medicine worth $34.4K as of Q3 2026.
  • Editas Medicine was a new E Fund Management position in Q3 2026.
  • Editas Medicine made up ﹤0.01% of E Fund Management's portfolio in Q3 2026, its #450 holding.
  • E Fund Management first reported a position in Editas Medicine in Q1 2022 and has held it in 11 quarters since.
  • E Fund Management's Editas Medicine position peaked at $465K in Q2 2022.
  • 221 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2026.

Based on E Fund Management's 13F filing for Q3 2026, filed 13 Nov 2026.